Director Global Strategic Planning - Digital Transformation, Sandoz International

Location: Holzkirchen, Germany
Job Type: Full-Time
Employer: Sandoz (Novartis Group)
Sandoz is currently recruiting for a Director Global Strategic Planning - Digital Transformation to join our Global Strategic Team to lead large-scale, global strategic initiatives to drive significant business improvement in digital area.

The purpose of the Director Global Strategic Planning role is to Manage multiple, cross-functional project teams ensuring rapid results generation of assigned initiatives.

Key Responsibilities

  • Set the digital aspiration for Sandoz and translate that into a tangible roadmap for the next 3-5 years and beyond
  • Closely collaborate with all Novartis divisions to identify synergies and opportunities along digital agenda and solutions
  • Drive the implementation across functions and geographies in Sandoz and track the success
  • Work with key stakeholders in top management to enable their “digital readiness” and informed decision making
  • Build and coordinate a small capable team to develop solutions on how we innovate, sell and operate
  • Act as the crystallization point for all digital topics of strategic value between Sandoz and external world, i.e.,
  • Respond to or identify business challenges within Sandoz which could be resolved by digital solutions and coordinate the solution
  • Identify new business models in the market (products and services) that may be a model for Sandoz and push their adoption in the division
  • Actively identify and start collaborations with external parties (e.g., startups) which can also be exploratory in nature
  • Help initiatives and colleagues (individually or in groups) to become more digital, more agile and more customer-centric

Minimum requirements

  • Significant experience at top tier consultancy (with relevant CXO interaction)
  • Proven experience as project manager is a must-have, ideally
  • First-hand experience in developing and delivering digital strategies/transformations along e.g,. multi-channel, web-enabled design, big data analytics, cloud computing, e-commerce etc.
  • Highly desired: Demonstrable track-record in building digital businesses, particularly as a founder
  • Savviness in innovative digital trends, e.g. IoT, Blockchain, Artificial Intelligence, Neural Networks etc
  • Top academic achievements
  • Fluency in English & at least 1 additional European language
  • Tested capability to successfully lead teams and projects, often with tight time constraints
  • Entrepreneurial spirit with Can-do, pro-active attitude
  • Excellent communication and presentation skills

Apply for this job

About Sandoz
Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2016 sales of USD 10.1 billion. In 2016, our products reached well over 500 million patients and we aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.

Sandoz Biopharmaceuticals, a global business unit of Sandoz, comprises biosimilars, contract manufacturing and Glatopa 20mg (glatiramer acetate). It is a USD one billion business (2016 annual sales). As the pioneer and global leader in biosimilars, with sales in 86 countries and five marketed biosimilars in Europe, Sandoz is committed to increasing patient access to high-quality, life-enhancing biosimilars. Its biosimilar products (Omnitrope, Binocrit, Zarzio/Zarzio, Rixathon and Erelzi) have generated more than 340 million patient days of experience. Sandoz has a leading biosimilar pipeline and plans to launch a total of five biosimilars of major oncology and immunology biologics across major markets between 2017 and 2020. A division of the Novartis Group, Sandoz is well-positioned to continue leading the biosimilars industry based on its experience and capabilities in development, manufacturing, and commercialization.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...